Company Filing History:
Years Active: 1976-1982
Title: The Innovative Contributions of Donald C. DeLong
Introduction
Donald C. DeLong is a prominent inventor based in Indianapolis, IN (US). He has made significant contributions to the field of antiviral research, holding a total of 9 patents. His work has been instrumental in developing new antiviral combinations that have the potential to impact public health.
Latest Patents
Among his latest patents are innovative antiviral combinations that include a 2-ester-substituted-3,4-dihydro-3-oxoquinoxaline and a hindered amine. These patents reflect his commitment to advancing antiviral therapies and addressing critical health challenges.
Career Highlights
Donald C. DeLong is associated with Eli Lilly and Company, a leading pharmaceutical firm known for its research and development in various therapeutic areas. His role at Eli Lilly has allowed him to collaborate with other talented professionals in the field.
Collaborations
Some of his notable coworkers include Robert L. Hamill and William M. Stark. Their collective expertise has contributed to the success of various projects and innovations within the company.
Conclusion
Donald C. DeLong's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions to antiviral research are paving the way for new treatments and improving health outcomes.